Phosphatase regenerating liver 3 participates in Integrinß1/FAK-Src/MAPK signaling pathway and contributes to the regulation of malignant behaviors in hepatocellular carcinoma cells.

Chen, Guobin; Zhang, Zhenzhen; Li, Jinghuan; Hu, Chao; Gao, Dongmei; Chen, Jun; Zhang, Lan; Xie, Xiaoying

Chen, Guobin; Zhang, Zhenzhen; Li, Jinghuan; Hu, Chao; Gao, Dongmei; Chen, Jun; Zhang, Lan; Xie, Xiaoying.

Afiliação

Chen G; Department of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Zhang Z; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China.
Li J; Department of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Hu C; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China.
Gao D; Department of Hepatic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Chen J; Department of Hepatic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang L; Department of Hepatic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xie X; Department of Hepatic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.

J Gastrointest Oncol ; 14(2): 863-873, 2023 Apr 29.

Article em En | MEDLINE | ID: mdl-37201051

Palavras-chave

Integrinß1; Phosphatase regenerating liver3 (PRL-3); hepatocellular carcinoma (HCC); malignant behavior

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google